| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/20/2001 | US6190921 Ouabain coupled to tyrosine, histidine, or a peptide or protein containing tyrosine or hisitidine, and attached to radioactive iodine, iodine isotope or specified lanthanide; use as tracer in ouabain immunoassays; low cross reactivity |
| 02/20/2001 | US6190918 Analyte detection device and process |
| 02/20/2001 | US6190917 Analyzing bitumen concentration in sample; controlling radiation exposure to sample, draw air through cavity, measure heat of ignited sample, moderate radiation to sample, reducing gaseous byproducts to carbon dioxide and water vapor |
| 02/20/2001 | US6190916 Troponin I composition |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190897 Nucleotide sequence coding hydrolase; for use in digestion of animal feeds |
| 02/20/2001 | US6190886 Trimerizing polypeptides, their manufacture and use |
| 02/20/2001 | US6190885 Fusion protein containing HMFG Epitop E (S) |
| 02/20/2001 | US6190881 Polynucleotide; recombinant production; drug screening of bactericides and enzyme inhibitors |
| 02/20/2001 | US6190878 Device and methods for determination of analyte in a solution |
| 02/20/2001 | US6190877 Placing sample into culutre media, incubating with fluorescent marker while retaining viabilty, activating with light to cause fluorescence, and viewing; fluorescence indicates malignancy or pre-malignancy |
| 02/20/2001 | US6190876 KUZ, a novel family of metalloproteases |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190874 Methods for identifying compounds that bind to CSAPK-1 |
| 02/20/2001 | US6190873 Mixing in aqueous medium the sample, a cyclosporin-label conjugate having specific linking groups, and antibodies capable of binding to cyclosporin-label conjugate; and determining presence of complex |
| 02/20/2001 | US6190872 Method for identifying and monitoring patients at risk for systemic inflammatory conditions and apparatus for use in this method |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190870 Efficient enrichment and detection of disseminated tumor cells |
| 02/20/2001 | US6190865 Accurate, simple method by amplifying dna using non-canonical deoxynucleoside triphosphate, contacting synthesized dna with an n-glycosylase to excise that base, fragmenting dna at the abasic sites, separating fragments by size |
| 02/20/2001 | US6190860 Method to detect CMV by hybridization with a gp55 specific DNA probe |
| 02/20/2001 | US6190858 Detection of conditions by analysis of gases or vapors |
| 02/20/2001 | US6190857 Diagnosis of disease state using MRNA profiles in peripheral leukocytes |
| 02/20/2001 | US6190856 Methods of detection utilizing modified bacteriophage |
| 02/20/2001 | US6190668 Providing cell mass of moraxella catarrhalis strain grown under iron-starved conditions to stimulate transferrin receptor protein expression; selectively extracting aqueous soluble proteins; separation; solubilizing; purification mass |
| 02/20/2001 | US6190662 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 02/20/2001 | US6190661 Methods and compositions for the use of apurinic/apyrimidinic endonucleases |
| 02/20/2001 | US6190657 Vectors for the diagnosis and treatment of solid tumors including melanoma |
| 02/20/2001 | US6190617 Sample container segment assembly |
| 02/20/2001 | US6190614 Needle washing block; blood and chemical analysis |
| 02/20/2001 | US6190611 Eriochrome black t, buffer, masking agents, magnesium ethylenediaminetetraacetate, and nonaqueous solvent; drinking water |
| 02/20/2001 | US6190610 Detection of contaminants in food |
| 02/20/2001 | US6190522 Analysis of carbohydrates derivatized with visible dye by high-resolution polyacrylamide gel electrophoresis |
| 02/20/2001 | US6190519 Gas sensor element |
| 02/20/2001 | US6190331 Estrogen or estradiol need determination by viginal acidity determination |
| 02/20/2001 | US6189394 On-line power sliding door test method |
| 02/20/2001 | US6189370 Fluid dose, flow and coagulation sensor for medical instrument |
| 02/20/2001 | US6189368 Method and apparatus for detection of concentration of hydrogen peroxide vapor |
| 02/20/2001 | CA2386542A1 Method and assembly for separating formed constituents from a liquid constituent in a complex biologic fluid sample |
| 02/20/2001 | CA2302629C Estrogen receptor |
| 02/20/2001 | CA2199403C Novel pka-binding proteins and uses thereof |
| 02/20/2001 | CA2197233C Methods of identifying compounds useful for treating autoimmune diseases |
| 02/20/2001 | CA2176361C Polyhydroxybutyrate and polyphosphate membranes with channels |
| 02/20/2001 | CA2119651C Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 02/20/2001 | CA2084036C Use of specific counteranions to modify the solubility of tetrazolium salts |
| 02/20/2001 | CA2016222C Method for spectroscopic analysis of hydrocarbons, and hydrocarbon refining operations using same |
| 02/20/2001 | CA2000685C Immunoassay on a preblocked solid surface |
| 02/20/2001 | CA1341182C Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 02/19/2001 | CA2316130A1 Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein |
| 02/15/2001 | WO2001011533A1 Method of recording gene analysis data |
| 02/15/2001 | WO2001011391A1 A method of determining parameters of formations through which a borehole passes |
| 02/15/2001 | WO2001011374A2 An automated point of care detection system including complete sample processing capabilities |
| 02/15/2001 | WO2001011373A2 Difference detection methods using matched multiple dyes |
| 02/15/2001 | WO2001011372A1 Annexins and autoantibodies used as markers for cancer |
| 02/15/2001 | WO2001011371A2 Diagnosis of inflammation measuring il-8 in urine |
| 02/15/2001 | WO2001011370A1 Use of acylsulfonamido-substituted polymethine dyes as fluorescence dyes and/or markers |
| 02/15/2001 | WO2001011369A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | WO2001011368A1 Method and reagent for assaying arthritis-associated melanotransferrin |
| 02/15/2001 | WO2001011367A1 Method of assyaing phosphorylation enzyme activity of cyclin/cdk complex |
| 02/15/2001 | WO2001011366A1 Antigenic components of selected indicator fungi and their use in methods and test kits |
| 02/15/2001 | WO2001011365A1 Method for detection of mite infection |
| 02/15/2001 | WO2001011363A1 Analytical method and apparatus |
| 02/15/2001 | WO2001011362A1 Cell counting method and kit |
| 02/15/2001 | WO2001011361A2 Kit and method to assess the malignancy of neoplasias |
| 02/15/2001 | WO2001011360A2 Relaxation of birefringence of magnetic nanoparticles during binding reactions |
| 02/15/2001 | WO2001011359A2 Color space analysis in biochemical and immunological assays |
| 02/15/2001 | WO2001011358A2 Use of colored metal binding proteins |
| 02/15/2001 | WO2001011357A2 Method of determining the oxygen requirement for the combustion of a fuel, method of combusting a fuel and an apparatus therefor |
| 02/15/2001 | WO2001011356A2 Methods and apparatus for determining coagulation times |
| 02/15/2001 | WO2001011354A2 Methods for characterizing, classifying, and identifying unknowns in samples |
| 02/15/2001 | WO2001011351A1 Method for detecting single nucleotide polymorphism (snp) and point mutation in gene, detection apparatus and detection chip |
| 02/15/2001 | WO2001011347A2 Humidity sensor |
| 02/15/2001 | WO2001011342A1 Automated sample analysis system |
| 02/15/2001 | WO2001011341A2 A system for cell-based screening |
| 02/15/2001 | WO2001011340A1 Optical system analysis of cells |
| 02/15/2001 | WO2001011339A1 Method and apparatus for differentiating and enumerating leukocytes |
| 02/15/2001 | WO2001011337A1 Device for measuring retention forces exerted by an orthesis such as support stockings or tights |
| 02/15/2001 | WO2001011336A1 Direct aspiration-reaction and injection device and methods of use |
| 02/15/2001 | WO2001011335A2 Antiviral compounds that inhibit viral replication |
| 02/15/2001 | WO2001011334A2 Method of diagnosing irritable bowel syndrome and other diseases by detecting anti-saccharomyces cerevisiae antibody |
| 02/15/2001 | WO2001011333A2 Apparatus for real-time measurement of cellular response |
| 02/15/2001 | WO2001011322A1 Microsensor housing |
| 02/15/2001 | WO2001011310A1 Instruments for analyzing binding assays based on attenuation of light by thin films |
| 02/15/2001 | WO2001011135A1 Apparatus and method for measuring a garment |
| 02/15/2001 | WO2001011089A1 Novel method for screening compound for preventing or treating liver cell injury caused by hepatitis c virus and compound obtained by this method |
| 02/15/2001 | WO2001011087A2 Method of evaluating a gene transfer vector and gene transfer vector product interactions |
| 02/15/2001 | WO2001011086A2 Methods of screening for angiogenesis modulators |
| 02/15/2001 | WO2001011080A1 A printed circuit board, biosensor and method of using same |
| 02/15/2001 | WO2001011078A1 Amplification method for detection of target nucleic acids involving fluorescence energy transfer |
| 02/15/2001 | WO2001011077A2 Methods of diagnosing or treating irritable bowel syndrome and other disorders |
| 02/15/2001 | WO2001011076A1 In vivo high throughput toxicology screening method |
| 02/15/2001 | WO2001011075A2 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 02/15/2001 | WO2001011064A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | WO2001011054A1 CRYSTALLIZATION AND STRUCTURE DETERMINATION OF STAPHYLOCOCCUS AUREUS UDP-N-ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE (S. AUREUS MurB) |
| 02/15/2001 | WO2001011051A2 Chimeric proteins |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011047A2 Dna sequences isolated from human colonic epithelial cells |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011043A1 Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 02/15/2001 | WO2001011040A1 Tumor-associated antigen (r11) |
| 02/15/2001 | WO2001011038A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |